AKABY

ALK-Abelló A/S AKABY

Trading inactive

AKABY
ALK-Abelló A/S ABCZF
Abcam plc ISEE
IVERIC bio, Inc. GBT
Global Blood Therapeutics, Inc. ALPN
Alpine Immune Sciences, Inc. ARNA
Arena Pharmaceuticals, Inc. MRTX
Mirati Therapeutics, Inc. RETA
Reata Pharmaceuticals, Inc. CCXI
ChemoCentryx, Inc. TPTX
Turning Point Therapeutics, Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode AKABY ABCZF ISEE GBT ALPN ARNA MRTX RETA CCXI TPTX
6M 0.00 % 11.25 % 88.98 % 2.61 % 243.76 % 0.00 % 55.04 % 72.79 % 2.50 % 0.12 %
YTD 0.00 % 46.00 % 98.56 % 0.00 % 241.95 % 0.00 % -0.69 % 369.52 % 0.00 % 0.00 %
1Y 0.00 % 41.36 % 198.58 % 124.93 % 475.98 % 0.00 % 29.44 % 424.85 % 71.87 % 125.75 %
3Y 0.00 % 16.19 % 781.90 % -8.64 % 635.79 % 0.00 % -70.69 % 50.36 % 5.54 % 14.08 %
5Y 8.43 % 66.92 % 1 504.42 % 14.25 % 1 343.78 % 75.70 % -22.29 % 196.35 % 479.60 % 161.21 %
10Y 8.43 % 196.67 % 51.90 % 58.87 % 8.86 % 143.88 % 171.51 % 1 218.75 % 348.58 % 161.21 %
From the beginning 8.43 % 264.75 % 51.90 % 58.87 % 8.86 % 44.08 % 732.62 % 1 218.75 % 372.64 % 161.21 %

Dividend

ALK-Abelló A/S

Abcam plc